<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36224173</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>12</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study.</ArticleTitle><Pagination><StartPage>5663</StartPage><MedlinePgn>5663</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5663</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-022-33415-5</ELocationID><Abstract><AbstractText>With increasing numbers infected by SARS-CoV-2, understanding long-COVID is essential to inform health and social care support. A Scottish population cohort of 33,281 laboratory-confirmed SARS-CoV-2 infections and 62,957 never-infected individuals were followed-up via 6, 12 and 18-month questionnaires and linkage to hospitalization and death records. Of the 31,486 symptomatic infections,1,856 (6%) had not recovered and 13,350 (42%) only partially. No recovery was associated with hospitalized infection, age, female sex, deprivation, respiratory disease, depression and multimorbidity. Previous symptomatic infection was associated with poorer quality of life, impairment across all daily activities and 24 persistent symptoms including breathlessness (OR 3.43, 95% CI 3.29-3.58), palpitations (OR 2.51, OR 2.36-2.66), chest pain (OR 2.09, 95% CI 1.96-2.23), and confusion (OR 2.92, 95% CI 2.78-3.07). Asymptomatic infection was not associated with adverse outcomes. Vaccination was associated with reduced risk of seven symptoms. Here we describe the nature of long-COVID and the factors associated with it.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hastie</LastName><ForeName>Claire E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Institute of Health and Wellbeing, University of Glasgow, Glasgow, G12 8RZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lowe</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Institute of Health and Wellbeing, University of Glasgow, Glasgow, G12 8RZ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emergency Department, Queen Elizabeth University Hospital, Glasgow, G52 4TF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McAuley</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Public Health Scotland, Meridian Court, Glasgow, G2 6QQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, G4 0BA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winter</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0002-8293-9462</Identifier><AffiliationInfo><Affiliation>Sandyford Sexual Health Services, NHS Greater Glasgow and Clyde, Glasgow, G3 7NB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>Nicholas L</ForeName><Initials>NL</Initials><Identifier Source="ORCID">0000-0003-0533-7991</Identifier><AffiliationInfo><Affiliation>BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, EH16 4SU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Corri</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Aberdeen Centre for Health Data Science, University of Aberdeen, Aberdeen, AB25 2ZD, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Public Health Directorate, NHS Grampian, Aberdeen, AB15 6RE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Janet T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, G61 1QH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donnell</LastName><ForeName>Catherine A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Institute of Health and Wellbeing, University of Glasgow, Glasgow, G12 8RZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blane</LastName><ForeName>David N</ForeName><Initials>DN</Initials><Identifier Source="ORCID">0000-0002-3872-3621</Identifier><AffiliationInfo><Affiliation>Institute of Health and Wellbeing, University of Glasgow, Glasgow, G12 8RZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Browne</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Health and Wellbeing, University of Glasgow, Glasgow, G12 8RZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibbotson</LastName><ForeName>Tracy R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Institute of Health and Wellbeing, University of Glasgow, Glasgow, G12 8RZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pell</LastName><ForeName>Jill P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0002-8898-7035</Identifier><AffiliationInfo><Affiliation>Institute of Health and Wellbeing, University of Glasgow, Glasgow, G12 8RZ, UK. Jill.pell@glasgow.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>COV/LTE/20/06</GrantID><Acronym>CSO_</Acronym><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>CH/F/21/90010</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RG/20/10/34966</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RE/18/5/34216</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Nat Commun. 2022 Nov 1;13(1):6540. doi: 10.1038/s41467-022-34344-z</RefSource><PMID Version="1">36319644</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>12</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36224173</ArticleId><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-33415-5</ArticleId><ArticleId IdType="pii">10.1038/s41467-022-33415-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo, F.R. et al. Prevalence of long-term effects in individuals diagnosed with COVID-19: an updated living systematic review. Preprint at medRxiv10.1101/2021.06.03.21258317 (2021).</Citation></Reference><Reference><Citation>Han, Q., Zheng, B., Daines, L., Sheikh, A. Long-term sequelae of covid-19: a systematic review and meta-analysis of one-year follow-up studies on post-covid symptoms. Pathogens. 11, 269 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel SAM, Olde Hartman TC, Lucassen P, van Jaarsveld CHM. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam. Pr. 2022;39:159&#x2013;167. doi: 10.1093/fampra/cmab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J. Med Virol. 2022;94:253&#x2013;262. doi: 10.1002/jmv.27309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini AM, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int J. Clin. Pr. 2021;75:e14357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Poudel AN, et al. Impact of Covid-19 on health-related quality of life of patients: a structured review. PLoS ONE. 2021;16:e0259164. doi: 10.1371/journal.pone.0259164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0259164</ArticleId><ArticleId IdType="pmc">PMC8553121</ArticleId><ArticleId IdType="pubmed">34710173</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat. Commun. 2022;13:1957. doi: 10.1038/s41467-022-29521-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison, S., Walters, B., Simmons, Z., Cook, M., Clark, R. The effectiveness of vaccination against long COVID: a rapid evidence briefing. In: UK Health Security Agency DoHaSS, ed. London https://ukhsa.koha-ptfs.co.uk/cgi-bin/koha/opac-detail.pl?biblionumber=64359 (2022).</Citation></Reference><Reference><Citation>Aly-Aly, Z., Benjamin, B., Xie, Y. Long Covid after Breakthrough COVID-19: the post-acute sequelae of breakthrough COVID-19. ResearchSquare https://www.researchsquare.com/article/rs-1062160/v1 (2021).</Citation></Reference><Reference><Citation>Antonelli M, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect. Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi, P. et al. Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel. npj Vaccines7, 101. (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9411827</ArticleId><ArticleId IdType="pubmed">36028498</ArticleId></ArticleIdList></Reference><Reference><Citation>Senjam, S.S. et al. Assessment of post COVID-19 health problems and its determinants in North India: a descriptive cross section study. Preprint at medRxiv10.1101/2021.10.03.21264490 (2021).</Citation></Reference><Reference><Citation>Simon, M.A., Luginbuhl, R.D., Parker, R. Reduced incidence of long-COVID symptoms related to administration of COVID-19 Vaccines Both Before COVID-19 Diagnosis and Up to 12 Weeks After. Preprint at medRxiv10.1101/2021.11.17.21263608 (2021).</Citation></Reference><Reference><Citation>Taquet, M., Dercon, Q., Harrison, P.J. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun.103, 154&#x2013;162 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold, D.T. et al. Are vaccines safe in patients with Long COVID? A prospective observational study. Preprint at medRxiv10.1101/2021.03.11.21253225 (2021).</Citation></Reference><Reference><Citation>Ayoubkhani D, et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleaton N, et al. The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shielding. Rheumatol. Int. 2021;41:707&#x2013;714. doi: 10.1007/s00296-021-04797-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04797-4</ArticleId><ArticleId IdType="pmc">PMC7871319</ArticleId><ArticleId IdType="pubmed">33559727</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen JM, et al. Use of SMS-linked electronic surveys for COVID-19 case investigation and contact tracing - Marin County, CA, USA. Public Health Pr. (Oxf.) 2021;2:100170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8320401</ArticleId><ArticleId IdType="pubmed">34345874</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathur R, et al. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Lancet. 2021;397:1711&#x2013;1724. doi: 10.1016/S0140-6736(21)00634-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00634-6</ArticleId><ArticleId IdType="pmc">PMC8087292</ArticleId><ArticleId IdType="pubmed">33939953</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotland&#x2019;s Census: Ethnicity. https://www.scotlandscensus.gov.uk/census-results/at-a-glance/ethnicity/#:~:text=Scotland&#x2019;s%20population%20was%2096.0%25%20white,ethnic%20groups%20doubled%20to%204%25 (2011).</Citation></Reference><Reference><Citation>Scottish Index of Multiple Deprivation https://www.gov.scot/collections/scottish-index-of-multiple-deprivation-2020/ (2020).</Citation></Reference><Reference><Citation>HDR-UK. Phenotype Library. https://phenotypes.healthdatagateway.org/phenotypes/.</Citation></Reference><Reference><Citation>Sigfrid L, et al. What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? - A harmonised, global longitudinal observational study protocol. BMJ Open. 2021;11:e043887. doi: 10.1136/bmjopen-2020-043887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-043887</ArticleId><ArticleId IdType="pmc">PMC7948153</ArticleId><ArticleId IdType="pubmed">33692181</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>